Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up January 02, 2015Vol.37 No.12
Drugs & Targets FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza January 02, 2015Vol.37 No.12
FreeTCCL Archive Cyramza Combination Approved in Advanced Gastric Cancer December 01, 2014Vol.37 No.11
FreeTCCL Archive Galeterone Shows Potential in CRPC AR Variants, Study Says December 01, 2014Vol.37 No.11
FreeTCCL Archive Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm December 01, 2014Vol.37 No.11
FreeTCCL Archive Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis December 01, 2014Vol.37 No.11
